Nobivac Parvo-C

A live vaccine against parvovirus in dogs. This product may only be prescribed by your veterinary practitioner from whom advice must be sought.

Product Information for Veterinary Healthcare Professionals

Nobivac Parvo-C contains live, attenuated, freeze dried, virus vaccine containing canine parvovirus, grown in cell line tissue culture. Each vial contains a single dose for reconstitution prior to use. 

For active immunisation of dogs against canine parvovirus. Protects against CPV type 2, type 2a and type 2b.

The company recommends that puppies are vaccinated with Nobivac DHPPi + Nobivac L4 twice, 4 weeks apart, with the final vaccination at an age of more than 10 weeks as a basic course of vaccination. If however prior to starting that basic vaccination course protection against CPV is required, an additional vaccination with Nobivac Parvo-C is advised.

For uses, dosage, contra-indications and warnings please consult product leaflet. Further information is available on request. Use medicines responsibly. 

Legal Category 


Packaging Quantities 

Clear, Glass Type I (PhEur) single vials with halogenobutyl rubber stopper, closed with a colour-coded aluminium cap. Cartons containing 10 or 50 vials. 

Summary of Product Characteristics

For Summary of Product Characteristics, first click on this link. Then type in Nobivac Parvo in Product name field. Click on Run search. Subsequently click on View SPC on line listing opposite Nobivac Parvo-C.